Norge -
norsk -
Statens legemiddelverk
mirtazapin bluefish 30 mg
bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 30 mg
Norge -
norsk -
Statens legemiddelverk
mirtazapin orion 30 mg
orion corporation orion pharma - mirtazapin - smeltetablett - 30 mg
Norge -
norsk -
Statens legemiddelverk
mirtazapin orion 15 mg
orion corporation orion pharma - mirtazapin - smeltetablett - 15 mg
Norge -
norsk -
Statens legemiddelverk
mirtazapin orion 45 mg
orion corporation orion pharma - mirtazapin - smeltetablett - 45 mg
Norge -
norsk -
Statens legemiddelverk
mirtazapin orion 15 mg
orion corporation - espoo - mirtazapin - tablett, filmdrasjert - 15 mg
Norge -
norsk -
Statens legemiddelverk
mirtazapin orion 30 mg
orion corporation - espoo - mirtazapin - tablett, filmdrasjert - 30 mg
Norge -
norsk -
Statens legemiddelverk
mirtazapin orion 45 mg
orion corporation - espoo - mirtazapin - tablett, filmdrasjert - 45 mg
Norge -
norsk -
Statens legemiddelverk
sativex 27 mg/ ml / 25 mg/ ml
jazz pharmaceuticals ireland limited - dronabinol / cannabidiol - munnspray, oppløsning - 27 mg/ ml / 25 mg/ ml
Den europeiske union -
norsk -
EMA (European Medicines Agency)
vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemi, myeloid, akutt - antineoplastiske midler - vyxeos liposomal er indisert for behandling av voksne med nylig diagnostisert, terapi-i forbindelse med akutt myelogen leukemi (t-aml) eller aml med myelodysplasia-relaterte endringer (aml-mrc).
Den europeiske union -
norsk -
EMA (European Medicines Agency)
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.